Breast Feeding < Breast Neoplasms < British Columbia

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000013 (2013)	Joy Melnikow [États-Unis] ; Daniel J. Tancredi ; Zhuo Yang ; Dominique Ritley ; Yun Jiang ; Christina Slee ; Svetlana Popova ; Phillip Rylett ; Kirsten Knutson ; Sherie Smalley	Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
000056 (2013)	Sepideh Saadatmand [Pays-Bas] ; Madeleine M A. Tilanus-Linthorst ; Emiel J T. Rutgers ; Nicoline Hoogerbrugge ; Jan C. Oosterwijk ; Rob A E M. Tollenaar ; Maartje Hooning ; Claudette E. Loo ; Inge-Marie Obdeijn ; Eveline A M. Heijnsdijk ; Harry J. De Koning	Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
000079 (2012)	Chung Y. Kong [États-Unis] ; Janie M. Lee ; Pamela M. Mcmahon ; Kathryn P. Lowry ; Zehra B. Omer ; Jonathan D. Eisenberg ; Pari V. Pandharipande ; G Scott Gazelle	Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections.
000137 (2011)	N T Van Ravesteyn [Pays-Bas] ; E A M. Heijnsdijk ; G. Draisma ; H J De Koning	Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.
000139 (2011)	John T. Schousboe [États-Unis] ; Karla Kerlikowske ; Andrew Loh ; Steven R. Cummings	Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
000220 (2009)	Charlotte Hsieh Ahern [États-Unis] ; Yu Shen	Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.
000246 (2008)	Quirine Lamberts Okonkwo [Pays-Bas] ; Gerrit Draisma ; Arno Der Kinderen ; Martin L. Brown ; Harry J. De Koning	Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
000247 (2008)	Janie M. Lee [États-Unis] ; Daniel B. Kopans ; Pamela M. Mcmahon ; Elkan F. Halpern ; Paula D. Ryan ; Milton C. Weinstein ; G Scott Gazelle	Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.
000263 (2007)	Eric S. Meadows [États-Unis] ; Robert Klein ; Matthew D. Rousculp ; Lee Smolen ; Robert L. Ohsfeldt ; Joseph A. Johnston	Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia.
000265 (2007)	J H Groenewoud [Pays-Bas] ; J D M. Otten ; J. Fracheboud ; G. Draisma ; B M Van Ineveld ; R. Holland ; A L M. Verbeek ; H J De Koning	Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands.
000278 (2006)	Harry J. De Koning [Pays-Bas] ; Gerrit Draisma ; Jacques Fracheboud ; Arry De Bruijn	Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.
000303 (2005)	Yu Shen [États-Unis] ; Giovanni Parmigiani	A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
000306 (2004)	M M Vervoort [Pays-Bas] ; G. Draisma ; J. Fracheboud ; L V Van De Poll-Franse ; H J De Koning	Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.
000307 (2004)	Eric J. Feuer [États-Unis] ; Ruth Etzioni ; Kathleen A. Cronin ; Angela Mariotto	The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.
000312 (2004)	J H Groenewoud [Pays-Bas] ; R M Pijnappel ; M E Van Den Akker-Van Marle ; E. Birnie ; T. Buijs-Van Der Woude ; W P Th M. Mali ; H J De Koning ; E. Buskens	Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.
000335 (2001)	B P Will [Canada] ; K M Nobrega ; J M Berthelot ; W. Flanagan ; M C Wolfson ; D M Logan ; W K Evans	First do no harm: extending the debate on the provision of preventive tamoxifen.
000344 (2000)	R J Connor [États-Unis] ; R. Boer ; P C Prorok ; D L Weed	Investigation of design and bias issues in case-control studies of cancer screening using microsimulation.
000358 (1998)	K A Cronin [États-Unis] ; J M Legler ; R D Etzioni	Assessing uncertainty in microsimulation modelling with application to cancer screening interventions.
000359 (1997)	P G Warmerdam [Pays-Bas] ; H J De Koning ; R. Boer ; P M Beemsterboer ; M L Dierks ; E. Swart ; B P Robra	Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
000363 (1997)	M E Van Den Akker-Van Marle [Pays-Bas] ; C M Reep-Van Den Bergh ; R. Boer ; A. Del Moral ; N. Ascunce ; H J De Koning	Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.
000369 (1996)	K L Szeto [Nouvelle-Zélande] ; N J Devlin	The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=MicroSimulV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Breast Neoplasms" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Breast Neoplasms" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    MicroSimulV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Breast Neoplasms
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sun Mar 10 17:35:57 2024. Site generation: Sun Mar 10 17:47:34 2024